NCT06724978 - A Study of S-740792 in Healthy Adult Study Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

September 10, 2025

Study Completion Date

September 24, 2025

Conditions

Healthy Participants

Interventions

DRUG

S-740792 Suspension

Participants will receive S-740792 as an oral suspension.

DRUG

Midazolam

Participants will receive midazolam as a syrup.

DRUG

Placebo

Participants will receive placebo as an oral suspension.

DRUG

S-740792 Tablet

Participants will receive S-740792 as an oral tablet.

Trial Locations (1)

Fortrea Clinical Research Unit, Inc., Daytona Beach